BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Optivia Biotechnology Inc. 

115 Constitution Drive
Suite 7
Menlo Park  California  94025  U.S.A.
Phone: 650-324-3177 Fax: 650-324-1855


SEARCH JOBS




Industry
Biotechnology






 Company News
Optivia Biotechnology Inc. Awarded $1.8 Million SBIR Grant to Build Platform for Transforming Central Nervous System (CNS) Disease Drug Discovery and Development 10/2/2013 9:38:47 AM    More...
Optivia Biotechnology Inc. Wins CRO Leadership Award from Life Science Leader 6/4/2012 10:54:21 AM    More...
Optivia Biotechnology Inc. Awarded $1.85 Million SBIR Grant to Build Comprehensive Platform for Assessing Dangerous Drug-Drug Interactions 4/5/2011 10:45:33 AM    More...
Almost 300 New Jobs To Be Created By Three Pharma Firms: Optivia Biotechnology Inc., Global Research Services, LLC, and International Prevention Research Institute (iPRI) 3/16/2011 6:06:04 PM    More...
Optivia Biotechnology Inc. Signs Agreement With U.S. FDA to Assess Role of Dietary Supplements in Drug-Induced Liver Injury 2/1/2011 9:00:33 AM    More...
University of California, San Francisco (UCSF) and Optivia Biotechnology Inc. Collaborate to Predict Liver Toxicity of Drugs in Development 11/16/2010 9:57:40 AM    More...
Optivia Biotechnology Inc. Names Dr. Yuichi Sugiyama to Scientific Advisory Board 11/15/2010 11:59:26 AM    More...
Optivia Biotechnology Inc. Launches Comprehensive Assay Suite to Assess Transporter-Related Drug-Drug Interactions and Improve Drug Safety 5/11/2010 11:15:17 AM    More...